ME/CFS is a chronic, complex, disabling condition which affects millions of people worldwide, often beginning during adolescence or early adulthood. Because most medical schools and educational resources do not cover ME/CFS adequately, patients are often met with skepticism and up to 90% of those afflicted remain undiagnosed or are misdiagnosed. Even when patients are diagnosed, healthcare providers often do not feel confident about managing their condition. Finally, accumulating evidence has resulted in a recent sea change in the standard of care: graded exercise therapy (GET) ad cognitive behavioral therapy (CBT) are no longer considered to be effective and may even cause harm. For these reasons, healthcare professionals would benefit both from basic education about ME/CFS as well as updated information regarding treatment and clinical care.
Dates and Times
Start: 8/21/2020 10:00 AM
End: 8/21/2020 3:00 PM
- Translate insights/lessons learned form patients developing ME/CFS after Severe Acute Respiratory Syndrome (SARS, a coronavirus) to the COVID-19 pandemic.
- Assess study protocols intended to track post COVID-19 ME/CFS cases or to describe the course of COVID-19 infections in ME/CFS patients.
- Treat patients effectively and safely with low-dose naltrexone, oral rehydration solution, and behavioral self-management techniques.
- Explain how immunological, autonomic, and metabolic dysfunction contribute to the pathophysiology of ME/CFS and might serve as biomarkers.
- Develop an approach to managing homebound and severely affected ME/CFS patients.
- Discuss how integrated, cross-disciplinary, and international research/clinical networks might accelerate clinical and scientific progress.
Stony Brook University
100 Ncolls Rd - Virtual
Stony Brook, NY 11794
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 4.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.